Alumis Inc. (ALMS) vs Savara Inc. (SVRA)

Alumis Inc. and Savara Inc. are both Biotechnology companies. Alumis Inc. and Savara Inc. are of similar size ($1.0B and $985.9M). Savara Inc. has the higher net margin (0.00% vs −5,933.5%) and the lower return on invested capital (−12,213.2% vs 0.00%). Across the 14 metrics below, Alumis Inc. leads on 8 and Savara Inc. on 6.

Valuation

Metric ALMS SVRA Biotechnology median
P/E n/m n/m 7.88
P/S 122.55 n/m 11.47
P/B 2.01 8.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 54.65 n/m 10.73
Earnings yield (54.37%) (11.60%) (28.84%)
Free cash flow yield (38.80%) (8.73%) (23.03%)

Profitability

Metric ALMS SVRA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (6,204.39%) 0.00% 0.00%
Net margin (5,933.45%) 0.00% 0.00%
Free cash flow margin (4,755.33%) 0.00% 0.00%
Return on equity (93.65%) (105.48%) (57.72%)
Return on assets (74.94%) (78.28%) (49.22%)
Return on invested capital 0.00% (12,213.18%) 0.00%

Growth

Metric ALMS SVRA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 72.45% (10.42%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ALMS SVRA Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 6.74 10.13 4.73
Net debt to EBITDA 0.69 1.64 0.96

Dividend

Metric ALMS SVRA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ALMS SVRA Biotechnology median
Market cap 985.86m 1.04b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack